General Information of Drug (ID: DM02MRW)

Drug Name
Remestemcel-L
Synonyms MSC-100-IV
Indication
Disease Entry ICD 11 Status REF
Crohn disease DD70 Phase 3 [1]
Graft-versus-host disease 4B24 Phase 3 [2]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
D1U5BA
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT01233960) Evaluation of PROCHYMAL for Treatment-refractory Moderate-to-severe Crohn's Disease. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT02652130) Safety Follow-up of Treatment With Remestemcel-L in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD. U.S. National Institutes of Health.